Patients with advanced HIV type 1 infection initiating antiretroviral therapy in Botswana: treatment response and mortality. (Q40798485)

23 September 2017

Patients with advanced HIV type 1 infection initiating antiretroviral therapy in Botswana: treatment response and mortality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

main subject

Botswana

0 references

anti-retroviral agent

0 references

1

Andrew Mujugira

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

5

Tendani Gaolathe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

author name string

C William Wester

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

Soyeon Kim

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

Hermann Bussmann

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

publication date

1 February 2009

1 reference

AIDS Research and Human Retroviruses

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

page(s)

127-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

Natural history of HIV infection in the era of combination antiretroviral therapy

13 May 2020

cites work

1 reference

12 December 2020

Human immunodeficiency viruses in the developing world.

1 reference

12 December 2020

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

12 December 2020

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

12 December 2020

Findings from the first national clinical audit of treatment for people with HIV.

1 reference

12 December 2020

Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

1 reference

12 December 2020

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte dʼIvoire

1 reference

12 December 2020

Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

1 reference

12 December 2020

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

12 December 2020

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

1 reference

12 December 2020

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy

1 reference

12 December 2020

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

1 reference

12 December 2020

Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability

1 reference

12 December 2020

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

12 December 2020

Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana

1 reference

12 December 2020

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

12 December 2020

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.

1 reference

12 December 2020

Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda

1 reference

12 December 2020

Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country

1 reference

12 December 2020

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

1 reference

12 December 2020

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

1 reference

12 December 2020

Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

1 reference

12 December 2020

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes

1 reference

12 December 2020

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

1 reference

12 December 2020

Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi

1 reference

12 December 2020

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries

1 reference

12 December 2020

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya

1 reference

12 December 2020

Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda.

1 reference

12 December 2020

Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation

1 reference

12 December 2020

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

12 December 2020

Identifiers

DOI

10.1089/AID.2008.0172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6463982&resulttype=core&format=json

13 May 2020

1 reference